Safety Norms: Clinical Research and Regulatory Affairs

1Purpose, Scope, and Safety Principles

These norms set minimum expectations for protecting people involved in clinical research and for keeping regulatory activity accurate, timely, and compliant. The purpose is to prevent participant harm, staff injury, infection transmission, privacy breaches, and inaccurate submissions. They apply to sponsors, contract research organizations, investigative sites, and staff who plan, conduct, monitor, or document studies, as well as regulatory affairs staff who prepare, review, or submit records to authorities.

Three principles guide every activity. Participant welfare outranks study timelines and recruitment targets. The protocol and approved procedures are followed unless an emergency requires immediate action to protect life or health. Anything not documented is treated as not done, so records must be contemporaneous and attributable to a named person.

• Mandatory: no study procedure starts before the ethics and regulatory approvals required in the relevant jurisdiction are on file.
• Mandatory: protocol deviations are reported under the sponsor and site procedure, never silently corrected.
• Recommended: maintain a single index of current approvals, document versions, and contacts for each study.
• Jurisdiction-dependent: approval pathways and review timelines vary and must be verified with the competent authority and ethics committee.

2Roles, Competence, and Accountability

The principal investigator holds overall responsibility for participant safety and protocol compliance at the site. The principal investigator may delegate tasks only in writing to staff who are trained and qualified. Sponsors hold responsibility for study oversight, monitoring, safety reporting, and the investigational product supply chain. Regulatory affairs staff are accountable for accurate submissions, correspondence tracking, and maintaining the regulatory binder or its electronic equivalent.

Competence must be demonstrated before work begins, not assumed from a job title. Delegation logs, training records, and license or credential checks are kept current. Staff who cannot perform a task safely must stop, escalate, and request supervision. Scope of practice boundaries apply to clinicians, coordinators, and regulatory writers alike. No one performs clinical assessments, dosing decisions, or eligibility judgments outside their authorized role.

• Mandatory: maintain a delegation of authority log signed by the principal investigator before any staff member performs protocol tasks.
• Mandatory: verify professional licenses and required training are current before assignment and at each renewal.
• Recommended: assign a named backup for critical roles such as safety reporting and drug accountability.
• Mandatory: declare and record conflicts of interest before a person takes part in study decisions.

3Course-Specific Hazards and Risk Assessment

Realistic hazards in clinical research include participant harm from study procedures or investigational products, delayed recognition of serious adverse events, exposure to bloodborne pathogens and other biological material, needle and sharps injuries, improper handling of hazardous or cytotoxic agents, privacy breaches involving identifiable health information, and regulatory violations caused by inaccurate or late documentation. Risk is judged by severity and likelihood, and hazards that could seriously harm participants receive the most attention.

Before each new study or major amendment, the site and sponsor complete a documented risk assessment covering the population, procedures, product, setting, and staff roles. Assessments are reviewed when a protocol changes, when a safety signal appears, or when audit findings identify weaknesses. Local procedures should define a simple scale, such as low, medium, and high, with clear criteria for each level.

• High: eligibility errors that expose participants to unsafe conditions, unreported serious adverse events, and dosing errors.
• High: unsecured identifiable participant data, including records left on shared printers or in unlocked cabinets.
• Medium: specimen handling, sharps use, and storage of investigational product outside validated conditions.
• Medium: missed submission deadlines or inconsistent version control of protocols and consent forms.
• Low: minor clerical discrepancies corrected through the approved correction process.

4Preventive Controls and Safe Work Practices

Preventive controls work best when they are built into the study workflow. Screening and eligibility checks use the current protocol version and a second-person verification for high-risk criteria. Investigational products are stored, dispensed, and returned under documented accountability. Study procedures are performed only by trained staff following approved worksheets. Any change to a procedure requires a protocol amendment or an approved deviation pathway before use.

Regulatory submissions follow the same discipline. Each document is checked for version, approval status, signatures, and consistency with other submitted materials. Labeling, safety narratives, and correspondence with authorities are reviewed by a qualified second reviewer before release. Where a legal or regulatory requirement is unclear, the team confirms it with the sponsor, ethics committee, or competent authority rather than relying on memory or prior practice.

• Mandatory: use only the current ethics-approved version of protocols, consent forms, and participant materials.
• Mandatory: a second qualified person verifies eligibility for criteria that are irreversible or high risk.
• Mandatory: investigational product is dispensed only against a valid order and recorded in the accountability log at the time of action.
• Mandatory: every protocol deviation is documented, assessed for participant impact, and reported within sponsor timelines.
• Recommended: use visit checklists covering vital sign measurement, specimen labeling, and temperature checks of storage units.
• Mandatory: regulatory documents are not submitted until a second reviewer has checked signatures, version numbers, and cross-references.

5Consent, Privacy, and Information Security

Informed consent is a process, not a signature alone. Staff must confirm that the person consenting is the participant or a legally authorized representative where local rules permit one. They must confirm the consent form version is current and that questions are answered in language the participant understands. Participants may withdraw at any time. Consent must be obtained before any study-specific procedure, and re-consent is required when material new information emerges. Interpreter use and assent processes follow local rules and the approved plan.

Privacy and information security protect participants and the integrity of study data. Identifiable information is minimized, coded, and transferred only through approved channels. Electronic systems require unique user accounts, role-based access, audit trails, and prompt removal of access when staff leave. Privacy laws and data protection rules vary by jurisdiction and must be verified with the institutional privacy office.

• Mandatory: never begin a consent discussion using an outdated or unapproved form.
• Mandatory: never send identifiable participant information through personal email accounts or unapproved messaging apps.
• Mandatory: lock paper records and log out of electronic systems when leaving a workstation.
• Recommended: run periodic access reviews of study systems and remove dormant accounts without waiting for an audit.

6Infection Prevention, Equipment, and Environment

Clinical research sites handle blood, body fluids, specimens, and sharps, and may host participants with contagious conditions. Standard precautions apply to every participant. Hand hygiene is performed before and after participant contact, after glove removal, and after touching shared equipment. Personal protective equipment is selected according to the task risk assessment and the site infection prevention policy. Staff are trained to put it on and remove it correctly.

Equipment and environment controls include calibrated devices, cleaned and documented surfaces, safe sharps disposal, and temperature-controlled storage for investigational products and specimens. Calibration certificates and environmental monitoring records are kept current. Manufacturer instructions for cleaning agents, device operation, and storage conditions are followed and confirmed with the vendor, because technical limits differ by product.

• Mandatory: dispose of needles and lancets immediately in puncture-resistant sharps containers placed within arm's reach of the procedure.
• Mandatory: never recap needles by hand, and report any needlestick exposure immediately.
• Mandatory: clean and disinfect shared equipment between participants using the agent named in the approved cleaning procedure.
• Mandatory: storage units outside approved temperature ranges trigger quarantine of affected product pending review.
• Recommended: post a visible contact card showing which precautions apply to each visit.

7Incident Reporting, Emergency Response, and Escalation

Every staff member must recognize and report a serious adverse event, unanticipated problem, protocol deviation, data breach, near miss, or product quality concern. Reports go to the designated person immediately. The principal investigator decides on participant-level actions. Sponsors and ethics committees set reporting timelines that may be short. These timelines are written into the site procedure and checked during training.

In a medical emergency, the first priority is participant safety. Staff call local emergency services or the site emergency response team, provide first aid within their competence, stop study procedures as needed, and document the event afterward. Study procedures never replace emergency treatment instructions. Staff never delay emergency care to obtain a signature or complete a form.

• Mandatory: report serious adverse events to the principal investigator and sponsor within the timelines in the protocol and local rules.
• Mandatory: call emergency services first for life-threatening events. This guidance does not replace clinical emergency protocols.
• Mandatory: report needlestick, splash, or spill exposures to occupational health during the same shift.
• Mandatory: notify the privacy office within the internal timeline when identifiable data is lost, misdirected, or accessed without authorization.
• Escalate to the principal investigator whenever a staff member is unsure whether an event is reportable.

8Records, Training, Monitoring, and Review

Good records show that participants were protected and that the study was conducted as approved. The regulatory binder or electronic trial master file holds approvals, training logs, delegation records, monitoring reports, correspondence, and safety reports. Corrections are made with a single line strike-through or an audit-trail entry showing the reason, the original entry, the time, and the person making the change. Retention periods vary by jurisdiction and must be verified.

Training precedes independent work and is refreshed when protocols, systems, or regulations change. Monitoring includes internal self-inspections, sponsor monitoring visits, and review of indicators such as deviation rates and open queries. Findings lead to corrective and preventive actions with named owners and target completion times. This section is reviewed at least once each review cycle and after any serious incident, audit, or inspection.

• Mandatory: training records show the protocol version and confirm the staff member completed it before performing related tasks.
• Mandatory: record corrections with the reason, original entry, and person making the change.
• Recommended: hold a short regular team huddle to review open safety issues and regulatory deadlines.
• Recommended: track trends such as deviations, late reports, and consent errors to guide improvement.

Implementation checklist

• Confirm the current approved protocol, consent form, and regulatory approvals are on file before any study activity.
• Verify delegation of authority and training records for each staff member performing study tasks.
• Use a second qualified reviewer for high-impact eligibility decisions and regulatory submissions.
• Confirm consent is obtained with the current form before any study procedure begins.
• Store identifiable data securely and send it only through approved channels.
• Dispose of sharps at the point of use and report any exposure during the same shift.
• Check storage temperature records and quarantine product that falls outside approved conditions.
• Report serious adverse events, deviations, and privacy breaches within the timelines in local procedures.
• Stop and escalate any task outside your authorized scope or training.
• Verify jurisdiction-dependent rules with the competent authority, ethics committee, or privacy office.